Literature DB >> 15752371

Comparative effects of glyceryl trinitrate and amyl nitrite on pulse wave reflection and augmentation index.

Lynn D Greig1, Stephen J Leslie, Fraser W Gibb, Sherilyn Tan, David E Newby, David J Webb.   

Abstract

AIMS: The influence of vasodilators on augmentation index (AIx) offers a simple, rapid and noninvasive method of evaluating vascular function. Glyceryl trinitrate (GTN) is widely used as an endothelium-independent vasodilator, although other nitrates that are shorter acting may have advantages in clinical studies. The aim of this study was to compare the effects of two short-acting nitrates, GTN and amyl nitrite, which have differing pharmacodynamic profiles.
METHODS: Twenty-one healthy volunteers (15 male; mean age 35 years, range 21-56 years) attended on three occasions and received sublingual GTN (0.5 mg for 3 min), inhaled amyl nitrite (0.2 ml inhaled for 30 s), or no treatment in a randomized cross-over design. Haemodynamic responses of AIx, blood pressure and thoracic bioimpedance (heart rate, cardiac index) were assessed by measurement at baseline, every 60 s for the first 5 min, and then every 5 min for a further 55 min.
RESULTS: AIx was reduced by amyl nitrite (peak effect -9 +/- 2% at 1 min, P < 0.002) and GTN (peak effect -12 +/- 3% at 4 min, P < 0.05). Compared with amyl nitrite, the onset and offset of action of GTN was slower. Amyl nitrite initially increased heart rate by 27 +/- 4% (P < 0.001) and cardiac index by 13 +/- 3% (P < 0.001) whereas GTN had no significant effect (P > 0.05). Neither agent affected blood pressure.
CONCLUSIONS: GTN causes a slower and more sustained reduction in AIx than amyl nitrite. Although amyl nitrite causes a more rapid fall and recovery in AIx, it induces a reflex tachycardia that may limit interpretation of the initial (1 min) but not later (2 min) changes in AIx. The prolonged offset of GTN suggests that a sufficient washout period must be included when making repeated measures or when assessing the subsequent effects of other agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752371      PMCID: PMC1884783          DOI: 10.1111/j.1365-2125.2004.02334.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  25 in total

Review 1.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

2.  Heart rate dependency of pulse pressure amplification and arterial stiffness.

Authors:  Ian B Wilkinson; Nadia Haj Mohammad; Sian Tyrrell; Ian R Hall; David J Webb; Vince E Paul; Terry Levy; John R Cockcroft
Journal:  Am J Hypertens       Date:  2002-01       Impact factor: 2.689

Review 3.  Noninvasive assessment of arterial stiffness and risk of atherosclerotic events.

Authors:  James J Oliver; David J Webb
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-06       Impact factor: 8.311

4.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

5.  Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

Authors:  M A Creager; J P Cooke; M E Mendelsohn; S J Gallagher; S M Coleman; J Loscalzo; V J Dzau
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

6.  Non-invasive determination of cardiac output by Doppler echocardiography and electrical bioimpedance.

Authors:  D B Northridge; I N Findlay; J Wilson; E Henderson; H J Dargie
Journal:  Br Heart J       Date:  1990-02

7.  The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm.

Authors:  D T Mason; E Braunwald
Journal:  Circulation       Date:  1965-11       Impact factor: 29.690

8.  Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus.

Authors:  P J Chowienczyk; R P Kelly; H MacCallum; S C Millasseau; T L Andersson; R G Gosling; J M Ritter; E E Anggård
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

9.  Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm.

Authors:  M Dawes; P J Chowienczyk; J M Ritter
Journal:  Circulation       Date:  1997-05-06       Impact factor: 29.690

10.  Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia.

Authors:  A M Zeiher; T Krause; V Schächinger; J Minners; E Moser
Journal:  Circulation       Date:  1995-05-01       Impact factor: 29.690

View more
  2 in total

1.  The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men.

Authors:  Bart J Van der Schueren; Rebecca Blanchard; M Gail Murphy; John Palcza; Inge De Lepeleire; Anne Van Hecken; Marleen Depré; Jan N de Hoon
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

2.  Endothelial Microparticles as Potential Biomarkers in the Assessment of Endothelial Dysfunction in Hypercholesterolemia.

Authors:  Nik Nor Izah Nik Ibrahim; Razlina Abdul Rahman; Maryam Azlan; Aniza Abd Aziz; Aida Hanum Ghulam Rasool
Journal:  Medicina (Kaunas)       Date:  2022-06-19       Impact factor: 2.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.